tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

ConvaTec Executes Share Buyback as Part of $300 Million Program

Story Highlights
ConvaTec Executes Share Buyback as Part of $300 Million Program

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

ConvaTec ( (GB:CTEC) ) has provided an update.

ConvaTec Group PLC has announced the purchase of 1,501,379 ordinary shares as part of its $300 million share buyback program. This transaction, executed through UBS AG London Branch, reflects the company’s strategic initiative to manage its capital structure and potentially enhance shareholder value. The shares will be held in treasury, and the company now holds a total of 20,795,865 shares in treasury, with 2,028,993,694 shares in issue. This move could impact the company’s market positioning by signaling confidence in its financial health and commitment to returning value to shareholders.

The most recent analyst rating on (GB:CTEC) stock is a Buy with a £260.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.

Spark’s Take on GB:CTEC Stock

According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.

ConvaTec’s overall stock score is driven primarily by its strong financial performance, which is offset by a cautious technical outlook and a relatively high valuation. The company’s robust financial health and effective cash flow management are significant strengths. However, the lack of positive technical indicators and a high P/E ratio suggest potential risks in the current market environment.

To see Spark’s full report on GB:CTEC stock, click here.

More about ConvaTec

ConvaTec Group PLC is a global medical products and technologies company that focuses on therapies for the management of chronic conditions. Its primary products and services include advanced wound care, ostomy care, continence and critical care, and infusion devices. The company is dedicated to improving the lives of patients and healthcare providers by offering innovative solutions in the medical field.

Average Trading Volume: 7,764,749

Technical Sentiment Signal: Hold

Current Market Cap: £4.78B

For a thorough assessment of CTEC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1